Overview of 
The Leatrice J. Nach Scientific Writing Program 

    This Program will blend and honor many of Lea's unique gifts and interests:

    • her insistence on meticulous writing (she was our ultimate editor and saved us from many a grammatical embarrassment!)
    • her love of scientific inquiry and the importance of pursuing the science of drug discovery
    • her love of networking (in Lea's Program, we will network with post-doctoral fellows who are gifted in scientific writing)
    • her love of teaching, as Lea's Program at ICAN will attract who are involved in or who want to enter the teaching field
    • her indomitable, indefatigable volunteer spirit.

    Lea's volunteer and senior leadership positions in the metropolitan Phoenix community – including her work with ICAN – were both innumerable and legendary. She had a huge impact on every organization with which she was associated, from decades-long associations with the Jewish community and passionate involvement in the arts and children's causes. She was the living embodiment of "tikkun olam" – the imperative of repairing the world.

    Lea filled so many roles at ICAN, and this is only a partial list:

    • Member, ICAN National Board of Advisors and Senior Advisor, Auxiliaries and Support Groups
    • Founding Advisory Council member and Member of the Leadership Council (1997)
    • Co-Chairman for 5 years, 2001-2005, ICAN Golf Tournaments
    • Co-Chairman for 3 years, 2001-2003, Jewels of the Sea Ball
    • Senior Office Volunteer since 1997 in charge of database review and event mailings
    • Strategic Planning Committee, Trash and Treasure Sales, ICAN, 2009
    • Editor, International Cancer Advocacy Network Cookbook, 2009

    Because of our Generous Supporters, ICAN patients involved in
    The Leatrice J. Nach Scientific Writing Program
    have access to the following information services:

  • A review and analysis of the patient's pathology report relating to TNM staging ("Tumor Node Metastasis"); review of the patient's medical history, diet, lifestyle and risk factors, current condition as well as any comorbid factors; and complete review of symptoms prior to presentation.
  • Referrals, at the patient contact's request, to medical oncologists, radiation oncologists, surgical oncologists, radiologists, interventional radiologists, anesthesiologists, and additional specialists relevant to the patient's ongoing care.
  • Referrals to support groups that may be of assistance in handling the emotional impact that cancer has on the patient and the patient's family.
  • Referrals to cancer-specific organizations that may be of assistance in addressing insurance issues or employment termination issues (because of diagnosis or disclosure of metastatic disease).
  • Review of the nature/amelioration of specific side effects from chemotherapy (such as nausea and neuropathy) as well as from other treatment modalities.
  • Discussion of the interaction of diet and cancer chemotherapy drugs based on recent studies.
  • Delineation of the symptoms about which the patient should alert his/her oncologist.
  • Discussion of relevant imaging technology.
  • Discussion of pain management issues and treatment options that can be addressed with the patient's medical team.
  • Explanation of the recommendations given or not given by the patient's physicians; assistance in answering the patient's questions which remain either after or between appointments with the medical team.
  • Review of the relevant radiotherapy/interventional radiology options which the patient contact, in turn, may discuss with his/her medical team.
  • Discussion of the relevance of the patient's specific immunohistochemistry and cytogenetic results to available clinical trials so that the patient may explore all options with his/her medical team.
  • Analysis of relevant colorectal cancer clinical trials options as well as the nature and purpose of clinical trials using Remission Coach®.
  • Review of relevant cancer-specific drugs in the anticancer pipeline.
  • Review of all relevant and complementary and alternative medicine ("CAM") avenues.
  • Review of the merits of filing a "Single Patient IND for Compassionate or Emergency Use" for a specific experimental cancer drug, if relevant to the patient's situation.
  • Exploration of options that might reduce travel costs for the patient contact, such as Corporate Angels Network, as well as ICAN supporters who have volunteered to host a clinical trials patient in a particular city.


The Leatrice J. Nach Scientific Writing Program
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.

For more information about this special program, please click on.....

  1. Main
  2. Photos
  3. Inspiration
  4. Memories
  5. Literature


ICAN is currently working on The Leatrice J. Nach Scientific Writing Program. We are working to put together a Family and Friends Advisory Council for the The Leatrice J. Nach Scientific Writing Program. If interested, please email us at LeatriceNachProgram@askican.org.

If you would like to become involved as a donor and supporter or a member of our Cancer Research Literature team as a Research Team Leader (medical school students, physicians, nurses, and post-docs only please), you may reach us at LeatriceNachProgram@askican.org.

Guidestar Platinum Seal of Transparency 2021

Federal Tax I.D.: EIN 86-0818253